v3.26.3
Stockholders’ Equity (Tables)
9 Months Ended
Sep. 30, 2026
Stockholders’ Equity [Abstract]  
Schedule of Ending Balance of RSU for the 2022 Plan

Ending balances for the 2022 Plan for the nine months ended September 30, 2026 are as follows:

 

Description   Number of
Shares
 
Shares available for future issuance under the 2022 Plan as of December 31, 2025     430,123  
Restricted stock units granted, net of forfeitures     (370,854 )
Common stock issued     (52,288 )
Shares available for future issuance under the 2022 Plan as of September 30, 2026     6,981  

 

Schedule of Summary of RSU Activity

A summary of RSU activity for the nine months ended September 30, 2026, is as follows:

 

    Number of
RSUs
    Weighted
Average
Grant
Price
 
Balance as of December 31, 2025     193,678     $ 16.65  
RSUs granted     477,017     $ 3.76  
RSUs vested     (57,779 )   $ 21.32  
RSUs forfeited     (106,163 )   $ 9.02  
Balance as of September 30, 2026     506,753     $ 5.59  
Schedule of Computation of Diluted Net Loss Per Share

The following table presents the securities that were excluded from the computation of diluted net loss per share because their inclusion would have been anti-dilutive:

 

    Balance as of September,  
Potential common shares excluded   2026     2025  
Warrants     436,022       1,475,757  
Restricted stock units     506,753       117,437  
Series A Preferred Stock, if converted(1)     3,880,682       260,757  
Total     4,823,457       1,853,951  

 

(1) Reflects the total common shares issuable upon conversion of the Series A Preferred Stock, including additional shares issuable under the shortfall settlement provision if the value of shares issuable at conversion is less than the Series A Preferred Stock’s guaranteed value, based on the common stock price as of the respective balance sheet date (see “Note 13 – Mezzanine Equity and Preferred Stock Embedded Derivative Liability”).